<DOC>
	<DOCNO>NCT02324140</DOCNO>
	<brief_summary>The study investigate inflammatory antiinflammatory response patient severe aortic valve stenosis need either surgical treatment ( surgical aortic valve replacement ) interventional cardiology treatment ( transcatheter aortic valve implantation use transfemoral access route transapical access route ) .</brief_summary>
	<brief_title>Inflammatory Response Aortic Valve Replacement</brief_title>
	<detailed_description>Background Surgical interventional therapy aortic valve stenosis expose patient immune reaction , different depend type treatment . In study , investigator would like good understand inflammatory antiinflammatory response patient population monitor perioperative cytokine response ( interleukin ) , human leukocyte antigen expression ( HLA-DR ) assess soluble plasma factor ( CD62L ) involve inflammatory process . Objective Characterisation inflammatory antiinflammatory response patient receive aortic valve prosthesis select different treatment option . Methods Whole blood analysis different time point ( preoperatively , 4 / 24 /48 hour postoperatively ) different inflammatory antiinflammatory marker : IL-6 , IL-8 , IL-10 , CRP , TNF , soluble CD62L .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
	<criteria>Written inform consent Severe aortic valve stenosis Surgical aortic valve replacement Transcatheter aortic valve implantation No previous inflammatory condition Exclusion Criteria Missing inform consent Treatment corticosteroid Treatment antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>